| P2093 | author name string | J Wayne Conlan | |
| | Susan M Twine | |
| | Kelly M Fulton | |
| | Robert V House | |
| | Mireille D Petit | |
| P2860 | cites work | Immunodominant Francisella tularensis antigens identified using proteome microarray. | Q51579914 |
| | Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. | Q53895179 |
| | Rapid immunodetection on polyvinylidene fluoride membrane blots without blocking | Q70817174 |
| | The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice | Q71661740 |
| | Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host geneti | Q73816633 |
| | Tularemia: a perusal of three hundred thirty-nine cases | Q76481815 |
| | Studies with tularemia vaccines in volunteers. III. Serologic aspects following intracutaneous or respiratory challenge in both vaccinated and nonvaccinated volunteers | Q79015674 |
| | Tularemia vaccine study. II. Respiratory challenge | Q79015704 |
| | Tularemia vaccine study. I. Intracutaneous challenge | Q79015708 |
| | Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines | Q79744513 |
| | Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- d | Q81488446 |
| | Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain | Q82138765 |
| | In vivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen | Q83859430 |
| | Proteomic analysis of the Escherichia coli outer membrane. | Q30870112 |
| | Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. | Q33215033 |
| | Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS. | Q33269973 |
| | Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A | Q33768818 |
| | CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice | Q34549016 |
| | Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion | Q35025586 |
| | A vaccine for tularaemia | Q35164813 |
| | Vaccines against Francisella tularensis--past, present and future | Q35791781 |
| | Tularemia vaccine: past, present and future | Q36147043 |
| | CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo | Q36403153 |
| | Vaccines against Francisella tularensis | Q36774993 |
| | Animal models of Francisella tularensis infection | Q36775013 |
| | An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes | Q37183341 |
| | Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis | Q37275515 |
| | Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. | Q37287818 |
| | Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans | Q37305453 |
| | Nature of protective immunity to Francisella tularensis. | Q38663749 |
| | Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity | Q39517769 |
| | In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. | Q39654574 |
| | Aerogenic immunization of man with live Tularemia vaccine | Q40720507 |
| | Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors | Q42047613 |
| | Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain | Q44068981 |
| | Francisella tularensis proteome: low levels of ASB-14 facilitate the visualization of membrane proteins in total protein extracts | Q46741767 |
| | Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans | Q46892532 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Francisella tularensis | Q1003460 |
| | attenuated vaccine | Q1810913 |
| | antibody | Q79460 |
| P304 | page(s) | e10000 | |
| P577 | publication date | 2010-04-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS) | |
| P478 | volume | 5 | |